Cargando…
Targeting Epigenetic Modifications in Uveal Melanoma
Uveal melanoma (UM), the most common intraocular malignancy in adults, is a rare subset of melanoma. Despite effective primary therapy, around 50% of patients will develop the metastatic disease. Several clinical trials have been evaluated for patients with advanced UM, though outcomes remain dismal...
Autores principales: | Chokhachi Baradaran, Pooneh, Kozovska, Zuzana, Furdova, Alena, Smolkova, Bozena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432398/ https://www.ncbi.nlm.nih.gov/pubmed/32726977 http://dx.doi.org/10.3390/ijms21155314 |
Ejemplares similares
-
Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy
por: Soltysova, Andrea, et al.
Publicado: (2020) -
KIT Expression Is Regulated by DNA Methylation in Uveal Melanoma Tumors
por: Horvathova Kajabova, Viera, et al.
Publicado: (2021) -
Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies
por: Jakubechova, Jana, et al.
Publicado: (2023) -
Early experiences of planning stereotactic radiosurgery using 3D printed models of eyes with uveal melanomas
por: Furdová, Alena, et al.
Publicado: (2017) -
Uncovering accurate prognostic markers for high‐risk uveal melanoma through DNA methylation profiling
por: Soltysova, Andrea, et al.
Publicado: (2023)